; and (B) home and community-based care. (2) Agreements The Secretary shall enter into agreements with eligible MA organizations under which such organizations shall offer eligible MA plans under the VBID demonstration program to eligible Medicare beneficiaries. (3) Limitations on number of plans for VBID demonstration program The VBID demonstration program shall be carried out with respect to not greater than 25 MA plans, with a minimum of 10 MA plans that serve rural or underserved areas. (4) Eligible MA plans defined For purposes of this section, the term eligible MA plan means a plan that, in addition to items and services for which coverage is otherwise provided under this part (including benefits under section 1852(a)(3) and notwithstanding any waivers under section 1915(c)), provides for coverage of— (A) tests that are medical devices (as defined in section 201(h) of the Federal Food, Drug, and Cosmetic Act or wearable patient monitoring device, including adaptive artificial intelligence, machine learning, and software as a medical device (SaMD) technologies that operate to the full scope of medical purpose defined by the Administrator of the Food and Drug Administration) and are identified by the Secretary as having appropriate at home use that is approved under section 505 of the Federal Food, Drug, and Cosmetic Act, and are either— (i) a diagnostic test or screening for the diagnosis of influenza or a similar respiratory condition that is required to obtain a final diagnosis of COVID–19 for an individual when such test is ordered by a physician or practitioner in conjunction with a COVID–19 diagnostic test or screening for purposes of discounting a diagnosis of influenza or a related diagnosis for such individual; (ii) a serology test for COVID–19; (iii) a diagnostic test or screening for the diagnosis of prostate cancer, ovarian cancer, breast cancer, hypothyroidism, rheumatoid arthritis, celiac disease, vascular inflammation, cardiovascular health, strep throat, or lipoprotein (A)